BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Byun JK, Lee S, Kang GW, Lee YR, Park SY, Song IS, Yun JW, Lee J, Choi YK, Park KG. Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induced ferroptosis in hepatocellular carcinoma. J Exp Clin Cancer Res 2022;41:98. [PMID: 35287706 DOI: 10.1186/s13046-022-02296-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Ding X, Yao T, Liu X, Fan Z, Liu Y. A macropinocytosis-related gene signature predicts the prognosis and immune microenvironment in hepatocellular carcinoma. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1143013] [Reference Citation Analysis]
2 Zhang R, Kang R, Tang D. Ferroptosis in gastrointestinal cancer: From mechanisms to implications. Cancer Lett 2023;:216147. [PMID: 36965540 DOI: 10.1016/j.canlet.2023.216147] [Reference Citation Analysis]
3 Nwosu ZC, Song MG, di Magliano MP, Lyssiotis CA, Kim SE. Nutrient transporters: connecting cancer metabolism to therapeutic opportunities. Oncogene 2023;42:711-24. [PMID: 36739364 DOI: 10.1038/s41388-023-02593-x] [Reference Citation Analysis]
4 Sankaran D, Amjesh R, Paul AM, George B, Kala R, Saini S, Kumar R. Hyperactivation of p21-Activated Kinases in Human Cancer and Therapeutic Sensitivity. Biomedicines 2023;11. [PMID: 36830998 DOI: 10.3390/biomedicines11020462] [Reference Citation Analysis]
5 Xia H, Huang Y, Zhang L, Luo L, Wang X, Lu Q, Xu J, Yang C, Jiwa H, Liang S, Xie L, Luo X, Luo J. Inhibition of Macropinocytosis Enhances the Sensitivity of Osteosarcoma Cells to Benzethonium Chloride. Cancers (Basel) 2023;15. [PMID: 36765917 DOI: 10.3390/cancers15030961] [Reference Citation Analysis]
6 Wang X, Li Y, Xiao Y, Huang X, Wu X, Zhao Z, Yang M, Kong L, Shi D, Chen X, Ouyang Y, Chen X, Lin C, Li J, Song L, Lin Y, Guan J. The phospholipid flippase ATP9A enhances macropinocytosis to promote nutrient starvation tolerance in hepatocellular carcinoma. J Pathol 2023. [PMID: 36715683 DOI: 10.1002/path.6059] [Reference Citation Analysis]
7 Li Y, Yang W, Zheng Y, Dai W, Ji J, Wu L, Cheng Z, Zhang J, Li J, Xu X, Wu J, Yang M, Feng J, Guo C. Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis. J Exp Clin Cancer Res 2023;42:6. [PMID: 36604718 DOI: 10.1186/s13046-022-02567-z] [Reference Citation Analysis]
8 Kim D, Kim M, Kim N, Lee S, Byun J, Yun JW, Lee J, Jin J, Kim J, Chin J, Cho SJ, Lee I, Choi Y, Park K. DN200434, an orally available inverse agonist of estrogen-related receptor γ, induces ferroptosis in sorafenib-resistant hepatocellular carcinoma. BMB Rep 2022;55:547-552. [DOI: 10.5483/bmbrep.2022.55.11.089] [Reference Citation Analysis]
9 Dong-Ho Kim, Mi-Jin Kim, Na-Young Kim, Seunghyeong Lee, Jun-Kyu Byun, Jae Won Yun, Jaebon Lee, Jonghwa Jin, Jina Kim, Jungwook Chin, Sung Jin Cho, In-Kyu Lee, Yeon-Kyung Choi, Keun-Gyu Park. DN200434, an orally available inverse agonist of estrogen-related receptor γ, induces ferroptosis in sorafenib-resistant hepatocellular carcinoma . BMB Rep 2022;55. [PMID: 36016501 DOI: 10.5483/BMBRep.2022.55.11.089] [Reference Citation Analysis]
10 Armenta DA, Laqtom NN, Alchemy G, Dong W, Morrow D, Poltorack CD, Nathanson DA, Abu-Remalieh M, Dixon SJ. Ferroptosis inhibition by lysosome-dependent catabolism of extracellular protein. Cell Chem Biol 2022;29:1588-1600.e7. [PMID: 36306785 DOI: 10.1016/j.chembiol.2022.10.006] [Reference Citation Analysis]
11 Zhu J, Wang H, Jiang X. mTORC1 beyond anabolic metabolism: Regulation of cell death. J Cell Biol 2022;221. [PMID: 36282248 DOI: 10.1083/jcb.202208103] [Reference Citation Analysis]
12 Yang Y, Li S, Wang Y, Zhao Y, Li Q. Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective. Sig Transduct Target Ther 2022;7. [DOI: 10.1038/s41392-022-01168-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 He J, Wang X, Chen K, Zhang M, Wang J. The amino acid transporter SLC7A11-mediated crosstalk implicated in cancer therapy and the tumor microenvironment. Biochem Pharmacol 2022;205:115241. [PMID: 36084707 DOI: 10.1016/j.bcp.2022.115241] [Reference Citation Analysis]
14 Li F, Long H, Zhou Z, Luo H, Xu S, Gao L. System Xc−/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. Front Pharmacol 2022;13:910292. [DOI: 10.3389/fphar.2022.910292] [Reference Citation Analysis]
15 Yoon SJ, Combs JA, Falzone A, Prieto-farigua N, Caldwell S, Ackerman HD, Flores ER, Denicola GM. The Origin of Cysteine and its Catabolism in Mammalian Tissues and Tumors.. [DOI: 10.1101/2022.08.26.505162] [Reference Citation Analysis]
16 Xiong Y, Chen L, Lin Z, Hu Y, Panayi AC, Zhou W, Sun Y, Cao F, Liu G, Dai G, Mi B, Liu G, Gao B. The Regulatory Role of Ferroptosis in Bone Homeostasis. Stem Cells International 2022;2022:1-9. [DOI: 10.1155/2022/3568597] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Li H, An Y, Gao J, Yang M, Luo J, Li X, Lv J, Li X, Yuan Z, Ma H. Recent Advances of Fluorescence Probes for Imaging of Ferroptosis Process. Chemosensors 2022;10:233. [DOI: 10.3390/chemosensors10060233] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Xu K, Liu X, Wen B, Liu Y, Zhang W, Hu X, Chen L, Hang W, Chen J. GSK-J4, a Specific Histone Lysine Demethylase 6A Inhibitor, Ameliorates Lipotoxicity to Cardiomyocytes via Preserving H3K27 Methylation and Reducing Ferroptosis. Front Cardiovasc Med 2022;9:907747. [DOI: 10.3389/fcvm.2022.907747] [Reference Citation Analysis]